About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

SLS-005

Company: Merit E. Cudkowicz, MD
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details

Active, not recruiting NCT NCT04297683

HEALEY ALS Platform Trial - Master Protocol

Not yet reported, Not yet reported Merit E. Cudkowicz, MD 1500 participants Est. completion 2028-08 81 sites Stand-alone

Other conditions: Amyotrophic Lateral Sclerosis
View official trial listing →
Completed NCT NCT05136885

HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose

Not yet reported, Not yet reported Merit E. Cudkowicz, MD 161 participants Est. completion 2023-08-25 1 site Stand-alone

Other conditions: Amyotrophic Lateral Sclerosis
View official trial listing →
Withdrawn NCT NCT05332678

SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease

Not yet reported Seelos Therapeutics, Inc. Est. completion 2023-04-10 3 sites Stand-alone

Other conditions: Alzheimer's Disease
View official trial listing →
Terminated NCT NCT05490563

STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia

Not yet reported, Not yet reported Seelos Therapeutics, Inc. 23 participants Est. completion 2023-11-24 23 sites Stand-alone

Other conditions: Spinocerebellar Ataxia Type 3
View official trial listing →
No Longer Available NCT NCT05597436

Intermediate-Sized Expanded Access Study

Seelos Therapeutics, Inc. 21 sites

Other conditions: Amyotrophic Lateral Sclerosis
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT05136885

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.